베인은 홈페이지 기능 및 성능 개선을 위해 쿠키를 사용합니다. 이와 관련된 더 많은 정보는 개인정보 메뉴에서 확인하실 수 있습니다. 이 웹사이트를 계속 사용하시면 쿠키 사용에 동의하신 것으로 간주됩니다. 

Industry

Rare Diseases

Rare Diseases

To win in the rare disease space, pharmaceutical companies need a unique business model and a carefully tailored set of capabilities across R&D, market access and customer engagement. We work with you to develop the strategy and operating model essential to succeed in this winner-takes-all market. 

Insights

Covid-19

As the human cost of COVID-19 rises the global pandemic is also sending shockwaves through the world economy. But, across industries and around the world, companies can take important actions now to protect the safety and health of their employees and customers, and mitigate the economic damage.

Learn more
)

What We Do

What We Do

Bain works with leading biopharmaceutical companies in the rare disease market to:

  • Design organizations that excel in rare diseases, from enterprise operating model and executive governance to commercial structures and ways-of-working
  • Accelerate speed-to-market by building fit-for-purpose research & development operating models, processes and infrastructure
  • Define the path and capabilities required to achieve a leadership position, and drive sustainable, profitable growth, including through transformative acquisitions
  • Prepare for rare disease drug launches that create maximum value, effectively navigating a marketing and access landscape that is unique to rare diseases
  • Create new pricing and access strategies for rare disease assets
  • Drive operational efficiencies to unlock savings and enable investments in line with your highest strategic priorities

Featured Team Members

베인에 궁금하신 점이 있으신가요?

베인은 글로벌 리더들이 중요한 이슈를 해결하고 기회를 놓치지 않도록 지원합니다. 고객사와 협력하여 지속되는 변화와 성과를 창출합니다.